Eurofins Scientific
ERFFrance
8 filed reports · 9 financial concepts · 15 earnings calls
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Revenue
—
Latest quarter
Filed reports
8 reports · Mar 2021 to Mar 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Q1AMF | 6 | 37 | Mar 2021 to Mar 2026 |
| Q3AMF | 2 | 24 | Sep 2022 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q1 | q1 | 2026-03-31 | 2026-04-22 | 8 | Open |
| FY2025 Q3 | q3 | 2025-09-30 | 2025-10-21 | 18 | Open |
| FY2025 Q1 | q1 | 2025-03-31 | 2025-04-23 | 11 | Open |
| FY2024 Q1 | q1 | 2024-03-31 | 2024-04-24 | 6 | Open |
| FY2023 Q1 | q1 | 2023-03-31 | 2023-04-26 | 3 | Open |
| FY2022 Q3 | q3 | 2022-09-30 | 2022-10-18 | 6 | Open |
| FY2022 Q1 | q1 | 2022-03-31 | 2022-04-21 | 5 | Open |
| FY2021 Q1 | q1 | 2021-03-31 | 2021-04-28 | 4 | Open |
Financial data
9 concepts · 61 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Segment1 concept · 46 facts · Mar 2021 to Mar 2026
- Revenue46 · Mar 2021 to Mar 2026
KPI5 concepts · 7 facts · Mar 2024 to Sep 2025
- blood collection points2 · Mar 2024 to Mar 2025
- new start-up laboratories2 · Mar 2024 to Mar 2025
- Blood collection points opened1 · Sep 2025
- Business combinations1 · Mar 2025
- Total1 · Sep 2025
IFRS1 concept · 6 facts · Mar 2021 to Mar 2026
- Revenue6 · Mar 2021 to Mar 2026
APM2 concepts · 2 facts · Mar 2022
- Q1 2022 organic growth rate (b/a-1)1 · Mar 2022
- Q1 2022 organic scope* revenues (at Q1 2022 FX rates) (b)1 · Mar 2022
Segments
46 factsFigures broken down by business line, region, product or another axis the company reports on.
Operating segment: europe1 member · 10 facts
- Europe10 · Mar 2021 to Mar 2026
Operating segment: north america1 member · 10 facts
- North America10 · Mar 2021 to Mar 2026
Operating segment: rest of the world1 member · 10 facts
- Rest of the World10 · Mar 2021 to Mar 2026
Area of activity: bio pharma1 member · 4 facts
- BioPharma4 · Mar 2025 to Mar 2026
Area of activity: consumer & technology products testing1 member · 4 facts
- Consumer & Technology Products Testing4 · Mar 2025 to Mar 2026
Area of activity: diagnostic services & products1 member · 4 facts
- Diagnostic Services & Products4 · Mar 2025 to Mar 2026
Area of activity: life1 member · 4 facts
- Life4 · Mar 2025 to Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
15 calls · Aug 2019 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q22026-07-23
- FY2026 Q12026-04-22
- FY2025 Q42026-01-29
- FY2025 Q32025-10-21
- FY2025 Q22025-07-23
- FY2025 Q12025-04-23
- FY2024 Q42025-01-30
- FY2024 Q32024-10-22
- FY2024 Q22024-07-24
- FY2024 Q12024-04-24
- FY2023 Q42024-02-27
- FY2023 Q32023-10-24
- FY2023 Q12023-04-26
- FY2022 Q42023-03-03
- FY2019 Q22019-08-29
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Eurofins Scientific (ERF) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.